Prostate biopsies are an essential tool for detecting prostate cancer, and about 3 million people worldwide undergo the procedure each year. Dr. Hu noted that physicians collect about 90% of these ...

Each year, more than a million transrectal biopsies are performed in the United States. The primary technique for diagnosing and monitoring prostate cancer, a transrectal biopsy, entails removing ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Technologies combining MRI, robotics, and artificial intelligence are changing the way prostate cancer is diagnosed and ...

The lower infection rate is particularly remarkable because the men in the transrectal biopsy group received a targeted course of antibiotics designed to help reduce their infection risk, and the men ...

Editor's note: An earlier version of this article misidentified a source in the story. He is Jim Hu, MD, not James Hu, MD. Researchers have concluded that transperineal prostate (TP) biopsies should ...

A multicenter randomized trial compared transperineal prostate biopsy without antibiotic prophylaxis versus transrectal biopsy with targeted prophylaxis, examining infections, prostate cancer ...

Investigators conclude that transperineal biopsy should be the standard of care for prostate biopsy. Prostate biopsy using a transperineal approach has a cancer detection rate similar to that of a ...

A multi-institutional clinical trial showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches. A ...